Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)
What is the purpose of this trial?
The purpose of this study is to compare any good and bad effects of using radium-223 along with docetaxel chemotherapy treatment versus using docetaxel alone.
- Ages18 years and older
- GenderMale only
- Trial withMemorial Sloan-Kettering Cancer Center
- Start Date11/26/2019
- End Date06/29/2022
- Last Updated12/02/2019
- Study HIC#2000023885